Artemisia and Green Tea Extracts for Gastric Mucosal Health

Exclusion Criteria

• •Patients with gastrointestinal symptoms requiring immediate drug treatment.
• •Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome.
• •Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial.
• •Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month.
• •Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year.
• •Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy.
• •Patients with uncontrolled hypertension (resting BP ≥160/100 mmHg).
• •Patients with uncontrolled diabetes (fasting glucose ≥160 mg/dL).
• •Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution.
• •Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution.
• •Alcohol abusers.
• •Individuals taking medications for psychiatric disorders (except those taking intermittent medication for sleep disorders).
• •Pregnant or breastfeeding women or those planning to become pregnant during the clinical trial period.
• •Individuals with allergies to any components of the study foods.
• •Individuals who participated in or plan to participate in another drug clinical trial within the last month.
• •Individuals deemed unsuitable for the study by the investigator for other reasons.